The estimated Net Worth of Stephen E. Paul is at least $685 millier dollars as of 2 May 2011. Stephen Paul owns over 9,000 units of Masimo Corp stock worth over $685,140 and over the last 16 years Stephen sold MASI stock worth over $0.
Stephen has made over 1 trades of the Masimo Corp stock since 2011, according to the Form 4 filled with the SEC. Most recently Stephen exercised 9,000 units of MASI stock worth $241,920 on 2 May 2011.
The largest trade Stephen's ever made was exercising 9,000 units of Masimo Corp stock on 2 May 2011 worth over $241,920. On average, Stephen trades about 2,250 units every 0 days since 2009. As of 2 May 2011 Stephen still owns at least 6,000 units of Masimo Corp stock.
You can see the complete history of Stephen Paul stock trades at the bottom of the page.
Stephen's mailing address filed with the SEC is C/O MASIMO CORPORATION, 40 PARKER, IRVINE, CA, 92618.
Over the last 17 years, insiders at Masimo Corp have traded over $198,004,099 worth of Masimo Corp stock and bought 212,683 units worth $10,354,127 . The most active insiders traders include Joe E Kiani, Edward L Cahill et Yongsam Lee. On average, Masimo Corp executives and independent directors trade stock every 14 days with the average trade being worth of $2,669,077. The most recent stock trade was executed by Joe E Kiani on 8 August 2024, trading 231,748 units of MASI stock currently worth $8,769,344.
masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.
Masimo Corp executives and other stock owners filed with the SEC include: